Zydus Pharmaceuticals (USA) Inc. is recalling approximately 270,125 vials of Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), a prescription medication used in clinical settings. The recall was initiated because routine testing found "out-of-specification" results for unknown degradation impurities, meaning the drug is breaking down into unintended chemical components faster than expected. Consumers and healthcare facilities should check their stock for affected lots distributed in MS, OH, LA, and Puerto Rico.
The presence of unknown degradation impurities means the drug may not be as effective as intended or could potentially cause unexpected side effects during medical procedures. Because this is a sterile injectable used for muscle relaxation during surgery or intubation, maintaining chemical purity is critical for patient safety.
Recall #: D-0623-2025; Manufactured by Zydus Lifesciences Ltd, Vadodara, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.